Market Tracker

09/30 6:05am ET

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

5.21
Data as of Sep 29
 +0.12 / +2.36%
Today’s Change
3.10
Today|||52-Week Range
10.64
+38.20%
Year-to-Date

Today’s Trading

Previous close5.09
Today’s open5.10
Day’s range-- - --
Volume573,247
Average volume (3 months)494,138
Market cap$302.9M
Dividend yield--
Data as of 09/29/2014

Growth & Valuation

Earnings growth (last year)+65.03%
Earnings growth (this year)+8.50%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+4.79%
P/E ratioNM
Price/Sales153.15
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc-0.35-4.77%
XNCRXencor Inc-0.21-2.19%
PTXPernix Therapeutics ...-0.22-2.80%
AGTCApplied Genetic Tech...-0.78-4.16%
Data as of 09/29/2014

Financials

Next reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$809.0K
Annual profit (last year)-$65.8M
Net profit margin-8,132.14%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts